BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Business

  Collaboration With Zydus Cadila Expires - Karo Bio AB Continues to Develop Safer Glucocorticoids

  April 2, 2012

   · 

  1 min read
• BioMidwest

  Exelixis, Inc.'s Cabozantinib to be Featured in Nine Presentations at 2012 American Society of Clinical Oncology Annual Meeting

  April 2, 2012

   · 

  1 min read
• Business

  Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Fourth Quarter Ended December 31, 2011

  April 2, 2012

   · 

  9 min read
• Business

  PLC Systems, Inc. Reports Fourth Quarter and Full Year 2011 Results

  April 2, 2012

   · 

  7 min read
• Business

  BIOTRONIK and Heartbeat International Celebrate Reaching Targets for Helping Cardiac Device Patients

  April 2, 2012

   · 

  4 min read
• Drug Development

  Cempra Pharmaceuticals, Inc. Presents Full Data Set of Phase 2 Clinical Trial of CEM-101 (Solithromycin) in Community-Acquired Bacterial Pneumonia Patients at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

  April 2, 2012

   · 

  5 min read
• Business

  Foundation Fighting Blindness Commits $2 Million to MitoChem Therapeutics for Developing a Vision-Saving Drug Treatment that Protects Mitochondrial Function

  April 2, 2012

   · 

  2 min read
• Elekta’s New Agility MLC Solution Poised to Revolutionize Beam Shaping of Radiation Therapy Cancer Treatments

  April 2, 2012

   · 

  4 min read
• Business

  ChromaDex, Inc. and Platinum Performance(R) Collaborate on Development of Platinum Longevity(TM), an Equine Supplement Featuring the Novel Ingredient pTeroGold(TM)

  April 2, 2012

   · 

  3 min read
• BioMidwest

  Genprex Release: Oncoprex Shows Synergistic Tumor Suppression in Combination with AKT Inhibitor MK2206

  April 2, 2012

   · 

  2 min read